The Relation of HLA Genotype to Hepatitis C Viral Load and Markers of Liver Fibrosis in HIV-infected and HIV-uninfected Women.

Mark H. Kuniholm,Xiaojiang Gao,Xiaonan Xue,Andrea Kovacs,Darlene Marti,Chloe L. Thio,Marion G. Peters,Ruth M. Greenblatt,James J. Goedert,Mardge H. Cohen,Howard Minkoff,Stephen J. Gange,Kathryn Anastos,Melissa Fazzari,Mary A. Young,Howard D. Strickler,Mary Carrington
DOI: https://doi.org/10.1093/infdis/jir192
2011-01-01
Abstract:Methods. High-resolution HLA class I and II genotyping was conducted in a prospective cohort of 519 human immunodeficiency virus (HIV)-seropositive and 100 HIV-seronegative women with persistent HCV infection. The end points were baseline HCV viral load and 2 noninvasive indexes of liver disease, fibrosis-4 (FIB-4), and the aspartate aminotransferase to platelet ratio index (APRI), measured at baseline and prospectively.Results. DQB1*0301 was associated with low baseline HCV load (beta = -.4; 95% confidence interval [CI], -.6 to -.3; P < .00001), as well as with low odds of FIB-4-defined (odds ratio [OR], .5; 95% CI, .2-.9; P = .02) and APRI-defined liver fibrosis (OR, .5; 95% CI, .3-1.0; P = .06) at baseline and/or during follow-up. Most additional associations with HCV viral load also involved HLA class II alleles. Additional associations with FIB-4 and APRI primarily involved class I alleles, for example, the relation of B*1503 with APRI-defined fibrosis had an OR of 2.0 (95% CI, 1.0-3.7; P = .04).Conclusions. HLA genotype may influence HCV viral load and risk of liver disease, including DQB1*0301, which was associated with HCV clearance in prior studies.
What problem does this paper attempt to address?